Every parent wants their child to grow up healthy, curious, and safe — and to those who might be taking a step forward to ...
While limited data suggest loncastuximab tesirine plus rituximab may be active in the third line, larger cohorts and ...
Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics ...
A research team led by scholars from Zhejiang University in East China has achieved the world's first non-invasive delivery ...
The Republic may not have a major player to call its own, but licensing deals and early-stage breakthroughs can still count ...
AstraZeneca’s Imfinzi approved in US as first and only perioperative immunotherapy for patients with early gastric and GEJ cancers: Cambridge, UK Thursday, November 27, 2025, 09 ...
Blenrep® (belantamab mafodotin) has been registered for use in adults with multiple myeloma who have relapsed or become resistant to first-line ...
Liver cancer, or hepatic cancer, is a malignant tumour that grows on the surface or inside the liver. The leading cause is a viral infection with hepatitis B or C virus. The most frequent liver ...
In a mouse model of the rare disease citrin deficiency, the authors discovered that the accumulation of glycerol-3-phosphate leads to ChREBP activation and FGF21 induction. The study identifies ...